Echocardiography and Structural Heart Symposium, 39th Annual
Live Symposium | 13.25 Cat. 1
October 27-28, 2022 | Thursday-Friday
Hilton Miami Airport Blue Lagoon, Miami, Florida
As valvular heart disease and structural heart treatments become more integral within cardiology, providers will rely on the diagnosis and treatment of disease using transcatheter/nonsurgical therapy.
The 39th Annual Echocardiography and Structural Heart Symposium – formerly known as the Echocardiography Symposium – will include successful topics from years past that focus on current guidelines for the evaluation of core topics within echocardiography, such as cardiac structure, cardiac function and hemodynamics assessment.
In addition, the internationally renowned faculty experts will address the latest developments, cutting-edge technologies and future directions of structural heart disease assessment, treatment options and advanced cardiac imaging.
These discussions will include advanced echocardiography imaging techniques (3-D, Strain, CT and TEE) and valve repair approaches (TAVR, mitral valve repair devices, left atrial appendage occlusion devices, paravalvular closure and alcohol septal ablation). Treatment focus will be on aortic, mitral and tricuspid valves and interatrial septum valvular heart disease, as well as specific patient populations, including those with cancer, atrial fibrillation, valvular heart disease and hypertrophic cardiomyopathy. Current controversies speak to indications and contraindications for various diagnostic and treatment approaches.
This year’s expanded focus will be of special interest to anesthesiologists, cardiologists, ED physicians, critical care physicians, sonographers and medical professionals interested in echocardiography and the newest advances in diagnosis and treatment of structural heart disease.
Agenda
Thursday, October 27 - 7 Cat. 1 Credits
7:00 a.m. | Registration, Continental Breakfast and Visit Exhibits |
7:45 a.m. | Welcome and Opening Remarks Barry Katzen, M.D. |
Aortic Stenosis Moderator: Elliott Elias, M.D. | |
8:00 a.m. | Introduction to Valvular Heart Disease and Guideline Updates Patrick T. O’Gara, M.D. |
8:15 a.m. | Sonographers' Corner: Evaluating Aortic Stenosis Elliott Elias, M.D. |
8:30 a.m. | Evaluating Low-Gradient Aortic Stenosis Severity and Outcomes in TAVR vs. SAVR Philippe Pibarot, DMV, Ph.D. |
8:45 a.m. | TAVR: Anatomy, Sizing, and High-Risk Features Omar Khalique, M.D. |
9:00 a.m. | Imaging Post-TAVR Philippe Pibarot, DMV, Ph.D. |
9:15 a.m. | Role of CMR in Aortic Stenosis João L. Cavalcante, M.D. |
9:30 a.m. | Case Presentation: A Difficult Decision of TAVR vs. SAVR for My Patient Nish Patel, M.D. |
9:50 a.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Patrick T. O’Gara, M.D., Philippe Pibarot, DMV, Ph.D., Omar Khalique, M.D., João L. Cavalcante, M.D., Nish Patel, M.D. |
10:00 a.m. | Break and Visit Exhibits |
Evaluation of Prosthetic Heart Valves Moderator: Elliott Elias, M.D. | |
10:15 a.m. | Prosthetic Heart Valves Patrick T. O’Gara, M.D. |
10:30 a.m. | Evaluation of Prosthetic Heart Valves: Form and Function Philippe Pibarot, DMV, Ph.D. |
10:45 a.m. | Case Presentation: TAVR Valve-in-Valve Ramon Quesada, M.D. |
11:00 a.m. | Clinical Conundrum: Is It Pathologic Obstruction or Prosthesis-Patient Mismatch? Philippe Pibarot, DMV, Ph.D. |
11:15 a.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Patrick T. O’Gara, M.D., Phillipe Pibarot, M.D., Ramon Quesada, M.D. |
11:25 a.m. | Lunch and Visit Exhibits |
Learning From the Experts on Valve Disease and How They Treat and Image It Moderator: Elliott Elias, M.D. | |
12:20 p.m. | Should Asymptomatic Severe Valvular Heart Disease Be Treated? Patrick T. O’Gara, M.D. |
12:35 p.m. | Using Advanced Imaging (Strain/Stress) to Assess MR Pre-Conception in an Athlete Eli Friedman, M.D. |
12:50 p.m. | Is Stress Echo Still Necessary? Partho P. Sengupta, M.D., D.M. |
1:05 p.m. | Unlocking the Mystery of When to Treat Severe Aortic Regurgitation Maurice Enriquez-Sarano, M.D. |
1:20 p.m. | Role of CMR in MR and Aortic Regurgitation João L. Cavalcante, M.D. |
1:35 p.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Eli Friedman, M.D., Partho P. Sengupta, M.D., D.M., Maurice Enriquez-Sarano, M.D., João L. Cavalcante, M.D. |
1:45 p.m. | Break and Visit Exhibits |
Building on the Basics of Echo with Advanced Imaging Moderator: Elliott Elias, M.D. | |
2:00 p.m. | What Is an Interventional Echocardiographer or a Structural Imager? Elliott Elias, M.D. |
2:15 p.m. | Prosthetic Assessment for Mitral Stenosis and Mitral Regurgitation Philippe Pibarot, DMV, Ph.D. |
2:30 p.m. | How Do I Quantify Valvular Heart Disease? (PISA, Continuity, Planimetry, Regurgitant Fraction, Percentage) Maurice Enriquez-Sarano, M.D. |
2:45 p.m. | Strain Without Stress: A Challenging Case in Cardio-Oncology Socrates Kakoulides, M.D. |
2:55 p.m. | Strain Imaging Partho P. Sengupta, M.D., D.M. |
3:10 p.m. | An Interesting Case of Constrictive vs. Restrictive Heart Disease Socrates Kakoulides, M.D. |
3:20 p.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Philippe Pibarot, DMV, Ph.D., Maurice Enriquez-Sarano, M.D., Socrates Kakoulides, M.D., Partho P. Sengupta, M.D., D.M. |
Multimodality Imaging for the Diagnosis and Treatment of Structural Heart Disease Moderator: Elliott Elias, M.D. | |
3:30 p.m. | Essential TEE Views and How They Relate to the Sonographer Elliott Elias, M.D. |
3:45 p.m. | Imaging and Treatment of Cardiac Shunts (ASD/VSD/PFO) Muhamed Saric, M.D., Ph.D. |
4:00 p.m. | Left Atrial Appendage Omar Khalique, M.D. |
4:15 p.m. | LVH and AS: Can I Tell If This Is Amyloidosis CMP? João L. Cavalcante, M.D. |
4:30 p.m. | Hypertrophic Cardiomyopathy and the Benefits of ETOH Ablations Muhamed Saric, M.D., Ph.D. |
4:45 p.m. | Assessing the Right Ventricle João L. Cavalcante, M.D. |
5:00 p.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Muhamed Saric, M.D., Ph.D., Omar Khalique, M.D. |
5:10 p.m. | Adjourn |
Friday, October 28 - 6.25 Cat. 1 Credits
7:00 a.m. | Registration, Continental Breakfast and Visit Exhibits |
7:45 a.m. | Welcome and Introductions Elliott Elias, M.D., Damian Chaupin, M.D. |
Mitral Valvular Disease Regurgitation and Right Heart Disease Moderator: Elliott Elias, M.D. | |
8:00 a.m. | Assessing Mitral Regurgitation Nadira Hamid, M.D. |
8:15 a.m. | Imaging for MitraClip and Transcatheter Mitral Valve Replacement (TMVR) Stephen H. Little, M.D. |
8:30 a.m. | Is MitraClip for Functional or Primary MR? Maurice Enriquez-Sarano, M.D. |
8:45 a.m. | Aortic Regurgitation and Upcoming Transcatheter Treatment Nadira Hamid, M.D. |
9:00 a.m. | An Introduction to TMVR Omar Khalique, M.D. |
9:15 a.m. | CT Planning for Mitral Valve Disease Constantino S. Pena, M.D. |
9:25 a.m. | My Toughest and Most Interesting Cases of TMVR Bernardo Lopez Sanabria, M.D. |
9:35 a.m. | Panel Discussion with Question-and-Answer Session Moderator: Elliott Elias, M.D. Faculty: Nadira Hamid, M.D., Stephen H. Little, M.D., Maurice Enriquez-Sarano, M.D., Bernardo Lopez Sanabria, M.D., Omar Khalique, M.D., Constantino S. Pena, M.D. |
9:50 a.m. | Break and Visit Exhibits |
Tricuspid Moderator: Damian Chaupin, M.D. | |
10:05 a.m. | Anatomy and Echo Imaging of Tricuspid Valve Nadira Hamid, M.D. |
10:20 a.m. | CT Planning for Tricuspid Valve Interventions Omar Khalique, M.D. |
10:35 a.m. | How Do I Evaluate Treat and Think About Transcatheter Treatment for Tricuspid Regurgitation Maurice Enriquez-Sarano, M.D. |
10:50 a.m. | My Toughest and Most Interesting Cases of Tricuspid Clip Ramon Quesada, M.D. |
11:00 a.m. | TEER for TR and an Update on Transcatheter Therapy and Data for Tricuspid Regurgitation Stephen H. Little, M.D. |
11:15 a.m. | Panel Discussion with Question-and-Answer Session Moderator: Damian Chaupin, M.D. Faculty: Nadira Hamid, M.D., Omar Khalique, M.D., Maurice Enriquez-Sarano, M.D., Ramon Quesada, M.D., Stephen H. Little, M.D. |
11:30 a.m. | Lunch and Visit Exhibits |
Advanced Imaging Moderator: Damian Chaupin, M.D. | |
12:25 p.m. | An Update on Mental Health and Imaging Orlando Santana |
12:35 p.m. | Evaluation of Mitral Stenosis Elliot Elias, M.D. |
12:45 p.m. | An Interesting Case of Mitral Stenosis: How to Use Strain and Stress to Guide Treatment Bernardo Lopez Sanabria, M.D. |
12:55 p.m. | Role of ICE in Transcatheter Therapy Muhamed Saric, M.D., Ph.D. |
1:10 p.m. | Diastology: How Technology Can Assist Us Partho P. Sengupta, M.D., D.M. |
1:25 p.m. | Endocarditis on the Native Valve and Prosthetic Valves and When to Send for Surgery Muhamed Saric, M.D., Ph.D. |
1:40 p.m. | When and How to Use 3D/4D Imaging Stephen H. Little, M.D. |
1:55 p.m. | Case Presentation: Paravalvular Leak Closure Nish Patel, M.D. |
2:10 p.m. | Panel Discussion with Question-and-Answer Session Moderator: Damian Chaupin, M.D. Faculty: Orlando Santana, Elliot Elias, M.D., Bernardo Lopez Sanabria, M.D., Partho P. Sengupta, M.D., D.M., Stephen H. Little, M.D., Nish Patel, M.D., Lowie Van Assche, M.D. |
Back To Basics Rapid-Fire Moderator: Damian Chaupin, M.D. | |
2:20 p.m. | Will Artificial Intelligence Replace the Clinical Echocardiographer? Damian Chaupin, M.D. |
2:30 p.m. | Imaging Assessment of Pulmonary Embolism Partho P. Sengupta, M.D., D.M. |
2:45 p.m. | Back to Basics for Aortic Stenosis and More Stephen H. Little, M.D. |
3:00 p.m. | Echocardiography and the Heart of an Athlete (Differentiating Adaptation from Pathology) Eli Friedman, M.D. |
3:15 p.m. | An Interesting But Uncommon Case of MR Elliott Elias, M.D. |
3:30 p.m. | Panel Discussion with Question-and-Answer Session Moderator: Damian Chaupin, M.D. Faculty: Elliott Elias, M.D., Partho P. Sengupta, M.D., D.M., Eli Friedman, M.D. |
3:40 p.m. | Closing Remarks Elliott Elias, M.D., Damian Chaupin, M.D. |
3:45 p.m. | Adjourn |
NOTE: Schedule subject to change.

The Miami Airport Hilton, just minutes from Miami International Airport, offers convenient access to beaches and attractions. Enjoy the 100-acre natural lake with jogging trail, outdoor pool and tennis and basketball courts. Indulge in spacious guest rooms and suites. This hotel was in the Top 20 of all Hotels in Miami 2015 by US News & World Report. Complimentary airport shuttle bus service is available.
Symposium Directors
![]() | Elliott J. Elias, M.D., MPH, FACC, FASE Cardiologist Medical Director of Cardiac and Structural Imaging Miami Cardiac & Vascular Institute Baptist Health South Florida |
![]() | Damian F. Chaupin, M.D. Cardiologist Miami Cardiac & Vascular Institute Baptist Health South Florida |
Faculty
![]() | João L. Cavalcante, M.D., FASE, FACC, FSCCT, FSCMR Director, Cardiac MRI and Structural CT Labs Minneapolis Heart Institute at Abbott Northwestern Hospital Director, Cardiovascular Imaging Research Center and Core Lab Minneapolis Heart Institute Foundation Associate Editor, European Heart Journal Associate Editor, Journal of Cardiovascular Computed Tomography Minneapolis, Minnesota |
![]() | Maurice Enriquez-Sarano, M.D., FACC, FAHA, FESC Professor, Senior Research Scientist Minneapolis Heart Institute Foundation and the Valve Science Center Minneapolis, Minnesota |
![]() | Eli Friedman, M.D. Medical Director of Sports Cardiology Baptist Health Medical Group Cardiology Miami Cardiac & Vascular Institute Baptist Health South Florida Miami, Florida |
![]() | Nadira Hamid, M.D. Assistant Professor of Medicine Assistant Director of Structural Heart Echocardiography Columbia University Irving Medical Center New York, New York |
![]() | Socrates V. Kakoulides, M.D. Medical Director, Diagnostic Center Miami Cardiac & Vascular Institute Baptist Health Medical Group Baptist Health South Florida Miami, Florida |
![]() | Omar Khalique, M.D. Director, Division of Cardiovascular Imaging Saint Francis Hospital and Catholic Health Director, Cardiovascular Imaging Research and Education DeMatteis Cardiovascular Institute Roslyn, New York |
![]() | Stephen H. Little, M.D. President, American Society of Echocardiography Director, Cardiovascular Fellowship Program Director of Structural Heart, Houston Methodist Hospital System John S. Dunn Chair in Clinical Cardiovascular Research and Education Professor of Medicine, Weill Cornell Medical College, Cornell University Dept. of Cardiology, Houston Methodist Hospital Houston, Texas |
![]() | Bernardo Lopez Sanabria, M.D. Interventional Cardiologist Miami Cardiac & Vascular Institute Baptist Health South Florida Miami, Florida |
Patrick T. O’Gara, M.D. Watkins Family Distinguished Chair in Cardiology Brigham and Women’s Hospital Professor of Medicine Harvard Medical School Boston, Massachusetts | |
![]() | Philippe Pibarot, DMV, Ph.D. Head of Cardiology Research Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval Professor, Department of Medicine Canada Research Chair in Valvular Heart Diseases Université Laval Quebec City, Quebec |
![]() | Ramon Quesada, M.D. Medical Director, Structural Heart, Complex PCI & Cardiac Research Miami Cardiac & Vascular Institute Baptist Health South Florida Miami, Florida |
![]() | Muhamed Saric, M.D., Ph.D. Director, Noninvasive Cardiology & Echo Lab Professor of Medicine New York University Langone Health New York, New York |
![]() | Partho P. Sengupta, M.D., D.M., FACC, FASE Henry Rutgers Professor of Cardiology Chief of Cardiovascular Medicine, Robert Wood Johnson Medical School Chief of Cardiovascular Service Line, Robert Wood Johnson University Hospital New Brunswick, New Jersey |
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 13.25 credit hours by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants, CE Broker Provider #50-182. 7 credits for the Thursday session (CE Broker #20-942804) and 6.25 credits for the Friday session (CE Broker #20-942808).
American Registry for Diagnostic Medical Sonography - Sonographers and vascular technologists may use these credits to fulfill their ARDMS requirements. The ARDMS accepts AMA PRA Category 1 Credits™.
Nurses and Respiratory Therapists - Approved on a session-by-session basis for a total of 13.0 contact hours by the Florida State Board of Nursing CE Broker Provider #50-182 (7.0 credits for the Thursday session and 6.0 credits for the Friday session).
Pharmacists and Pharmacy Technicians - Approved on a session-by-session basis for a total of 13.25 contact hours by the Florida State Board of Pharmacy, CE Broker Provider #50-182; (7.0 credits for the Thursday session and 6.25 credits for the Friday session).
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 13.25 AMA PRA Category 1 Credit™
- 13.25 General certificate of attendance
- 13.00 Nurse Practitioners
- 13.00 Florida Board of Nursing
- 13.25 Florida Board of Pharmacy
- 13.00 Florida Board of Respiratory Therapy
About the Exhibitors
Abbott
Abbott is the global leader in developing transcatheter mitral valve technologies as alternatives to open-heart surgery. Building upon its success with the MitraClip device and many years of mitral valve experience and clinical evidence, Abbott is also leading the way in novel, transcatheter devices by investing in the development and clinical study of new mitral valve replacement technologies.
AGFA Healthcare
Agfa HealthCare's Enterprise Imaging for Cardiology delivers a unified imaging ecosystem that speeds up image acquisition and retrieval and enhances the delivery of care.
It improves the cardiologist’s experience, by offering across all cardiology departments and modalities - Ultrasound, Cath lab, ECG, Nuclear Cardiology and MR&CT- web-based image viewing and access, advanced analysis applications, structured reporting, flexible workflow and collaboration tools – in ONE SINGLE WORKSPACE.
Agfa HealthCare Enterprise Imaging for Cardiology is part of our unified Enterprise Imaging Platform, built to reduce complexity, improve productivity and deliver value.
AtriCure
AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients.
AstraZeneca
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realize the potential of what science can do.
Biosense Webster
Increase insight into the heart during transseptal punctures. The ACUSON AcuNav™ Catheter provides high resolution 2D grayscale and Doppler models that help better understand structural orientation, visualize cardiac chamber borders and verify tissue contact. The ACUSON AcuNav™ Catheter is intended for intracardiac and intraluminal visualization of cardiac & great vessel anatomy and physiology as well as visualization of other devices in the heart
Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare.
B. Braun Interventional Systems
B. Braun Interventional Systems offers state of the art medical devices designed and developed to provide innovative solutions that add value, safety, efficiency, and precision to interventional procedures. Our products have been developed in collaboration with, and in response to, the specific needs of physicians, technologists and nurses with the intent to improve patient outcomes. Our product portfolios consist of angioplasty and valvuloplasty, congenital and structural heart, percutaneous drainage, vena cava filters, vascular access and interventional accessories, and have been developed to specifically address clinical needs in interventional radiology, pediatric and congenital interventional cardiology, vascular surgery and pulmonology.
Bracco Diagnostics
Bracco Diagnostics is a diagnostic imaging company with products for X-ray imaging, including computed tomography, magnetic resonance imaging, ultrasound and nuclear medicine
CardiaLine
CardiaLine is a medical device distribution company that specializes in comprehensive cardiopulmonary solutions. CardiaLine offers diagnostic and non-diagnostic cardiopulmonary monitoring systems, remote patient monitoring solutions and durable medical exercise equipment, with a specialty in cardiac and pulmonary rehab. CardiaLine has created partnerships with global companies such as Ergoline GmbH as we work to bring quality solutions to patient care.
Chiesi
Chiesi USA, Inc., headquartered in Cary, NC, is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. For more information, please visit www.chiesiusa.com or call our customer service department at (888) 466-6505
CIVCO Medical Solutions
CIVCO Medical Solutions works to make image-guided procedures safer. CIVCO manufactures products for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. CIVCO specializes in ASTRA automated high-level disinfection systems for TEE transducers, ultrasound viral barriers, and needle and device guidance.
East End Medical
The SafeCrossTM Transseptal RF Puncture and Steerable Balloon Introducer System is used for introducing various cardiovascular catheters into the heart, including the left side of the heart. The system enables left heart access through a puncture of the atrial septum during a transseptal catheterization procedure. In addition, the device can be used for monitoring intracardiac pressures, sampling blood, and infusing solutions.
Edwards Lifesciences
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
EKO
Eko, a digital health company, is advancing how healthcare professionals detect and monitor heart and lung disease with its innovative suite of digital tools, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.
Fujifilm Healthcare
Fujifilm Healthcare pioneered ultrasound for use by cardiovascular professionals since the 1960’s and we continue to lead the way with the introduction of our premium 2D and 3D ultrasound system, the LISENDO 880. Recognized for our outstanding image quality, Doppler performance, superior system reliability and intuitive use of cutting edge technology like Vector Flow Mapping(VFM), Fujifilm Healthcare remains the ideal choice for exceptional diagnostic ultrasound in Cardiovascular medicine. Our focus on hemodynamic analysis in echocardiography uniquely positions us to provide additional information not typically found in Fetal, Pediatric and Adult echocardiography. Fujifilm Healthcare is redefining the vision for cardiovascular ultrasound.
GE Cardiovascular Ultrasound
GE Healthcare is the $18 billion healthcare business of GE. As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.
Ginkgo Heart
The Cormeum app was designed to make managing heart failure easy. Patients can check in anytime to see their day by day, weekly or monthly progress. Best of all, they can share their results with you so that together you can collaborate on their care. Empower, educate and engage your patients by recommending Cormeum and providing them an opportunity to self-manage their heart failure.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is a global biopharmaceutical company that finds and delivers novel treatments for patients with significant unmet need. In March 2021, Kiniksa received FDA approval for ARCALYST® (rilonacept). Please visit www.Arcalyst.com/hcp to learn more.
Lantheus Medical Systems
With more than 60 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.
LSI Medical
In today’s every-changing healthcare environment, LSI leads the way in providing time-saving cardiac rehab solutions you trust, supported by relationships you rely on. Together, we keep your focus on where it’s needed most – on your patients.
Medtronic
We engineer the extraordinary to alleviate pain, restore health, and extend life.
Miami Cardiac & Vascular Institute
Miami Cardiac & Vascular Institute is the largest and most comprehensive cardiovascular facility in the region. The team of multilingual, multidisciplinary specialists pioneered the development of minimally invasive techniques used to treat aneurysms, blockages in veins and arteries and holes in the heart. The Institute leverages the power of Baptist Health’s combined resources of experts, pioneering research, compassionate caregivers and leading-edge treatments and technology.
MiCare Path
Building a closer connection with an ever-growing patient population, MiCare Path is a reimbursable integrated mobile health (mHealth)* platform delivering improved outcomes with data driven decisions, personalized patient education and care paths promoting clinical efficiencies for a better patient experience.
Novarad
Novarad has been providing medical imaging software solutions for over 30 years. We are experts in hospital deployment of CPACS and medical enterprise imaging and information software systems. Our software includes scalable and customizable solutions for 500+ bed hospitals down to 26 bed hospitals, Critical Access Hospitals, and Rural Hospitals. The NovaCardio solution is a complete motion cardiac imaging solution that allows viewing, efficient workflows, and cardiac structured reporting. In addition it allows physicians to use story boarding to graphically share the complete picture of a patient’s disease. Novarad has best-in-class, USA based, 24/7 Support.
NovoNordisk
Novo Nordisk purpose is to drive change to defeat diabetes and other serious chronic diseases such as CVD, obesity, rare blood and rare endocrine diseases. Novo Nordisk is the first pharmaceutical company to use 100% renewable power in all of their global production facilities. With their Circular for Zero strategy, they are starting a journey to achieve zero environmental impact in all of their business activities. Most important we strive in innovation to improve patient lives.
Pfizer Rare Disease
We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.
Philips Ultrasound
Today’s cardiology departments are under pressure to implement cutting-edge imaging solutions that will not compromise workflow efficiency, diagnosis, treatment or patient care. At Philips, we understand your challenges as well as your commitment to providing outstanding diagnosis and care, fast. We also believe that, through specialized, patient-centric care, we can improve both outcomes and experiences.
Rhythmedix Cardiac Monitoring
RhythMedix is a leading integrated provider of continuous, cloud based remote arrhythmia monitoring solutions serving physicians and their patients throughout the United States. Focused on innovation within the monitoring space, the latest 1-piece patch device continues to disrupt the marketplace by providing a 4-in-1 monitor without the burdensome need for a phone to complicate and delay sending data. Thus, allowing a quick and seamless patient experience.
Sanofi
Sanofi is an innovative, patient centric global healthcare company. We are committed to using state of the art technology to solve some of the world’s greatest health risks including cardiovascular disease and diabetes to improve our patient’s quality of life and longevity.
Siemens Healthineers
By constantly bringing breakthrough innovations to market, Siemens Healthineers enables healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. At Siemens Healthineers, our mission is to enable healthcare providers to increase their value by equipping them with our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. Our global portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the biggest challenges in healthcare. We will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.
Ultromics
Ultromics’ AI-powered platform, EchoGo, is revolutionizing echocardiography. Proven to predict patient outcomes, this groundbreaking solution automates complex analysis through a secure cloud connection. With unprecedented accuracy and zero variability, Ultromics empowers providers with superior heart disease detection and risk stratification.
ZOLL Medical
ZOLL Medical Corporation develops products to protect and manage cardiac patients, including the LifeVest wearable cardioverter defibrillator (WCD), ZOLL Cardiac Monitor, and ZOLL Heart Failure Management System.
Price
⚠ | COVID-19 Protocols Notice for All Attendees, Exhibitors and VendorsSelf-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person. Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity. |